Working... Menu
Trial record 11 of 179 for:    DCLRE1C

Assessment of Metabolic & Path Response w/ RCT & ImT Before Surgery in Locally Advanced Esoph and Gastro-esoph Jction CA (ARTEMIS-Eso)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03307941
Recruitment Status : Withdrawn (Suspended collaboration with the company providing the study drug)
First Posted : October 12, 2017
Last Update Posted : December 19, 2017
Innate Pharma
Information provided by (Responsible Party):
Jules Bordet Institute

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : December 11, 2017
  Actual Study Completion Date : December 11, 2017